We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




First Ever Prototype Applies AI to Colorectal Diagnosis

By LabMedica International staff writers
Posted on 08 Mar 2024
Print article
Image: The prototype uses AI as a complementary tool to the diagnosis of colon and rectal biopsies (Photo courtesy of INESC TEC)
Image: The prototype uses AI as a complementary tool to the diagnosis of colon and rectal biopsies (Photo courtesy of INESC TEC)

The incidence and mortality rates of colorectal cancer (CRC) are on an alarming rise, with predictions showing a continuous increase until at least 2040. Currently, CRC ranks as the third most diagnosed (10.7% of all cancer cases) and the second deadliest cancer type. Despite the effectiveness of imaging and endoscopic techniques in CRC detection, the final cancer diagnosis always relies on a pathologist's assessment of histological samples. Grading dysplasia is still routinely performed by pathologists worldwide when assessing colorectal tissue samples. Computer-aided diagnosis (CAD) systems for colorectal pathology face challenges due to the high data volume and the massive resolution of images, leading to a bottleneck in deep learning (DL) approaches that extract patches from the whole slides.

Now, researchers at INESC TEC (Porto, Portugal) and IMP Diagnostics (Porto, Portugal) have created a pioneering prototype that employs artificial intelligence (AI) for colorectal diagnosis. This prototype is a result of a technical innovation involving a new, more efficient training methodology that significantly reduces the number of images needed to train the AI model without compromising its effectiveness. The advancement not only enhances image analysis technology but also contributes to developing more efficient solutions for diagnosing colorectal cancer. The project focused on enhancing a prototype that utilizes AI as a supplementary tool for diagnosing colon and rectal biopsies and creating the most extensive digital image database of colorectal pathologies, now freely available for research and knowledge advancement.

This model was trained using approximately 10,000 images of tissues affected by colorectal pathology, achieving a diagnostic accuracy of 93.44% and a sensitivity of 99.7% in identifying high-risk lesions associated with this cancer type. Over half (5,300) of these images, amounting to nearly five terabytes of data, have been made accessible to the scientific community. The distribution of these digital images is part of IMP Diagnostics and INESC TEC's commitment to science promotion and scientific knowledge sharing, adhering to the FAIR principles. These international guidelines recommend that scientific data should be easily findable, accessible, interoperable, and reusable.

Pedro Neto, a researcher at INESC TEC, stated that “part of the images can be used to train other AI models, while the others will be used specifically for testing/benchmarking between AI tools – towards improving thoroughness and fairness when comparing said tools”.

Related Links:
INESC TEC
IMP Diagnostics

Gold Member
Turnkey Packaging Solution
HLX
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Fixed Volume Pipettor
Labpette FX
New
Respiratory Syncytial Virus Test
QuickVue RSV Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The LIAISON PLEX Gram-Negative Blood Culture Assay runs on the on the LIAISON PLEX instrument (Photo courtesy of Diasorin)

Molecular Multiplexing Panel for Blood Culture Identification Enables Targeted Treatment Decisions

Each year, approximately 250,000 patients in the US are diagnosed with bloodstream infections (BSIs). Sepsis resulting from BSIs has an average mortality rate of 16-40%, and any delays in initiating appropriate... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image

Revolutionary Molecular Culture ID Technology to Transform Bacterial Diagnostics

Bacterial infections pose a major threat to public health, contributing to one in five deaths worldwide. Current diagnostic methods often take several days to provide results, which can delay appropriate... Read more

Industry

view channel
Image: International expert meeting for trends and innovations in laboratory medicine - the MEDICA LABMED FORUM at MEDICA (Photo courtesy of Constanze Tillmann/Messe Düsseldorf)

MEDICA LABMED FORUM 2024: International Experts Meet to Discuss Trending Topics in Laboratory Medicine

At MEDICA (Düsseldorf, Germany), the world’s premier trade fair for the healthcare industry and medical technology sector, this year’s event (November 11–14) will focus on the most exciting medical advancements.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.